329 related articles for article (PubMed ID: 27884223)
1. Local Renin Angiotensin Aldosterone Systems and Cardiovascular Diseases.
De Mello WC
Med Clin North Am; 2017 Jan; 101(1):117-127. PubMed ID: 27884223
[TBL] [Abstract][Full Text] [Related]
2. New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II.
Zhuo JL; Li XC
Peptides; 2011 Jul; 32(7):1551-65. PubMed ID: 21699940
[TBL] [Abstract][Full Text] [Related]
3. [The ACE2/Ang(1-7)/Mas receptor axis in cardiovascular and renal diseases].
Kanda T; Itoh H
Nihon Rinsho; 2012 Sep; 70(9):1487-91. PubMed ID: 23012792
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-(1-7) inhibits vascular calcification in rats.
Sui YB; Chang JR; Chen WJ; Zhao L; Zhang BH; Yu YR; Tang CS; Yin XH; Qi YF
Peptides; 2013 Apr; 42():25-34. PubMed ID: 23291307
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system.
Santos RA; Ferreira AJ; Verano-Braga T; Bader M
J Endocrinol; 2013 Feb; 216(2):R1-R17. PubMed ID: 23092879
[TBL] [Abstract][Full Text] [Related]
6. [Expression and significance of ACE2-Ang-(1-7)-Mas axis in the endometrium of patients with polycystic ovary syndrome].
Qin S; Zhou YJ; Liu Y; Shen HM; Li XD; Yan X; Tang HJ
Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(25):1989-92. PubMed ID: 24169251
[TBL] [Abstract][Full Text] [Related]
7. Counter-regulatory effects played by the ACE - Ang II - AT1 and ACE2 - Ang-(1-7) - Mas axes on the reactive oxygen species-mediated control of vascular function: perspectives to pharmacological approaches in controlling vascular complications.
Pernomian L; Pernomian L; Baraldi Araújo Restini C
Vasa; 2014 Nov; 43(6):404-14. PubMed ID: 25339158
[TBL] [Abstract][Full Text] [Related]
8. Is hypertension in African-descent populations contributed to by an imbalance in the activities of the ACE2/Ang-(1-7)/Mas and the ACE/Ang II/AT
Cohall D; Ojeh N; Ferrario CM; Adams OP; Nunez-Smith M
J Renin Angiotensin Aldosterone Syst; 2020; 21(1):1470320320908186. PubMed ID: 32089050
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the renin-angiotensin system (RAS) in BeWo and HTR-8/SVneo trophoblast cell lines.
Wang Y; Pringle KG; Chen YX; Zakar T; Lumbers ER
Placenta; 2012 Aug; 33(8):634-9. PubMed ID: 22647832
[TBL] [Abstract][Full Text] [Related]
10. ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.
Mendoza-Torres E; Oyarzún A; Mondaca-Ruff D; Azocar A; Castro PF; Jalil JE; Chiong M; Lavandero S; Ocaranza MP
Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):217-37. PubMed ID: 26275770
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic targeting of the angiotensin-converting enzyme 2/Angiotensin-(1-7)/Mas cascade in the renin-angiotensin system: a patent review.
Ferreira AJ; Bader M; Santos RA
Expert Opin Ther Pat; 2012 May; 22(5):567-74. PubMed ID: 22510001
[TBL] [Abstract][Full Text] [Related]
12. Nuclear angiotensin-(1-7) receptor is functionally coupled to the formation of nitric oxide.
Gwathmey TM; Westwood BM; Pirro NT; Tang L; Rose JC; Diz DI; Chappell MC
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F983-90. PubMed ID: 20810609
[TBL] [Abstract][Full Text] [Related]
13. Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats.
Klimas J; Olvedy M; Ochodnicka-Mackovicova K; Kruzliak P; Cacanyiova S; Kristek F; Krenek P; Ochodnicky P
J Cell Mol Med; 2015 Aug; 19(8):1965-74. PubMed ID: 25766467
[TBL] [Abstract][Full Text] [Related]
14. The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle.
Henriksen EJ; Prasannarong M
Mol Cell Endocrinol; 2013 Sep; 378(1-2):15-22. PubMed ID: 22564510
[TBL] [Abstract][Full Text] [Related]
15. Alternative renin-angiotensin system pathways in adipose tissue and their role in the pathogenesis of obesity.
Slamkova M; Zorad S; Krskova K
Endocr Regul; 2016 Oct; 50(4):229-240. PubMed ID: 27941178
[TBL] [Abstract][Full Text] [Related]
16. Both aldosterone and spironolactone can modulate the intracellular ACE/ANG II/AT1 and ACE2/ANG (1-7)/MAS receptor axes in human mesangial cells.
Stoll D; Yokota R; Sanches Aragão D; Casarini DE
Physiol Rep; 2019 Jun; 7(11):e14105. PubMed ID: 31165585
[TBL] [Abstract][Full Text] [Related]
17. Counteraction between angiotensin II and angiotensin-(1-7) via activating angiotensin type I and Mas receptor on rat renal mesangial cells.
Xue H; Zhou L; Yuan P; Wang Z; Ni J; Yao T; Wang J; Huang Y; Yu C; Lu L
Regul Pept; 2012 Aug; 177(1-3):12-20. PubMed ID: 22561449
[TBL] [Abstract][Full Text] [Related]
18. Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.
Grace JA; Klein S; Herath CB; Granzow M; Schierwagen R; Masing N; Walther T; Sauerbruch T; Burrell LM; Angus PW; Trebicka J
Gastroenterology; 2013 Oct; 145(4):874-884.e5. PubMed ID: 23796456
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of disease: local renin-angiotensin-aldosterone systems and the pathogenesis and treatment of cardiovascular disease.
Re RN
Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):42-7. PubMed ID: 16265259
[TBL] [Abstract][Full Text] [Related]
20. Expression and function of the ACE2/angiotensin(1-7)/Mas axis in osteosarcoma cell lines U-2 OS and MNNG-HOS.
Ender SA; Dallmer A; Lässig F; Lendeckel U; Wolke C
Mol Med Rep; 2014 Aug; 10(2):804-10. PubMed ID: 24858078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]